Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Can Walgreen Keep Rebounding in 2013?

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

As 2013 begins, now's a good time to look at the future prospects for the stocks you own. If you don't know where a company's headed in the next year and beyond, then it's impossible to make an informed decision about whether you should add the stock to your portfolio -- or sell it if you already own it.

Today, I'll look at Walgreen (NASDAQ: WBA  ) . The drugstore chain bounced back in 2012 after having faced a huge strategic challenge, but it's still working hard to repair the damage. Below, you'll learn more about Walgreen's prospects for 2013.

Stats on Walgreen



Average Stock Target Price


Fiscal 2013 EPS Estimate


Fiscal 2014 EPS Estimate


Fiscal 2013 Sales Growth Estimate


Fiscal 2014 Sales Growth Estimate


Forward P/E


Source: Yahoo Finance.

Will Walgreen fill investors' prescriptions for growth in 2013?
Analysts have mixed feelings about Walgreen. Their target price for the stock isn't very ambitious, implying just a 5% gain from current share-price levels. Yet, with solid earnings growth and modest increases in sales, Walgreen should look better fundamentally as the year goes on.

Despite a resilient stock price, Walgreen is still struggling to get over the impact of the customers it lost during its dispute with pharmacy benefit manager Express Scripts (NASDAQ: ESRX  ) . With revenue from its fiscal first quarter down almost 5% from the year-ago quarter, and earnings plunging 25%, Walgreen hasn't been able to earn back former customers' loyalty.

You can tell just how big a deal the Express Scripts fiasco continues to be by looking at competitors' results. Rite Aid (NYSE: RAD  ) managed to earn a profit for the first quarter in five years thanks to the customers it gained from Walgreen. Meanwhile, CVS Caremark (NYSE: CVS  ) is pushing ahead in its efforts to retain its share of former Walgreen customers.

Still, Walgreen will press ahead in two major ways that are important for investors. First, Walgreen has an impressive 36-year dividend-increase streak that it should maintain easily. Second, its acquisition of Alliance Boots gives it growth opportunities in Europe, which is currently hard-hit by economic woes, but which should rebound, and give Walgreen the chance to boost its global presence.

Walgreen will have to work hard to recover; but with the right moves, it should be able to succeed. Meanwhile, with its 3% dividend, investors have every incentive to be patient holding the stock.

The stock market has soared to start 2013, but you could be up much more over the long term. In fact, The Motley Fool wants to give you a 98.79% chance at beating the market. If you're interested in the best odds in the universe -- including more than a 70% chance at doubling the market's return over the long haul -- here's some very good news for you: Motley Fool Supernova is reopening to new members for the first time ever on Jan. 15! Get instant and free access to learn how you can get these kinds of market-beating odds by clicking here now.

Click here to add Walgreen to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 13, 2013, at 10:37 PM, ctyank99 wrote:

    Who cares about WAG?


    I’ve been laughed at for liking this stock, but I see my local store with noticably more foot traffic and The action in the stock price has justified my belief that RAD is great stock.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2180087, ~/Articles/ArticleHandler.aspx, 9/25/2016 5:08:51 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,261.45 -131.01 -0.71%
S&P 500 2,164.69 -12.49 -0.57%
NASD 5,305.75 -33.78 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/23/2016 4:00 PM
WBA $82.05 Down -0.33 -0.40%
Walgreens Boots Al… CAPS Rating: ****
CVS $90.60 Up +0.03 +0.03%
CVS Health CAPS Rating: *****
ESRX $71.34 Up +0.31 +0.44%
Express Scripts CAPS Rating: *****
RAD $8.09 Down -0.03 -0.37%
Rite Aid CAPS Rating: ****